The Trump administration late Tuesday announced new lower Medicare prices for 15 drugs that were part of the latest round of ...

The United States has revealed price reductions for the second round of | The U.S. has revealed price reductions for the ...

The Centers for Medicare and Medicaid Services on Tuesday announced lower prices on 15 costly prescription drugs under ...

The Medicare health plan said on Tuesday that newly negotiated prices for 15 of its costliest drugs will save 36% on those ...

The Trump administration has announced new, lower Medicare prices for 15 drugs, including Ozempic, Wegovy, and key cancer treatments, effective in 2027.

73% lower for Trelegy Ellipta, which treats asthma and chronic obstructive pulmonary disease (COPD) and was taken by 1.3 million Medicare Part D enrollees last year. 60% lower for Pomalyst, which ...

The Centers for Medicare & Medicaid Services announced Nov. 25 that Medicare recipients will pay less for 15 prescription ...

Negotiations are expected to continue in future cycles as part of President Donald Trump's "aggressive push for lower prices.

A European consortium of researchers has developed a new decision making framework for health professionals which they hope ...

Zein became aware of alcohol’s impact on COPD a few years ago. In a paper published in 2021, Zein and colleagues found that ...

The 2026 version of the Global Initiative for Chronic Obstructive Lung Disease (GOLD) strategy report has been published. Key ...

The GOLD COPD Update 2026 provides updated guidance on case-finding, disease activity, exacerbation management.